Johnson and Johnson await approval for distribution of vaccine
Johnson & Johnson takes the next big step in production for its coronavirus (COVID-19) vaccine requesting emergency authorization for use from the FDA. This request comes weeks after the release of the promising data of 66% effective in protecting against the virus.
Johnson & Johnson says that it could produce 1 billion doses of its COVID-19 vaccine — enough to vaccinate about an eighth of the world’s population — by the end of the year. https://t.co/oHnVcQeaqM
— Science News (@ScienceNews) February 5, 2021
If the new vaccine is approved, Johnson & Johnson will offer the third COVID-19 vaccine approved for emergency use in the U.S. and will also start the process of approval for worldwide use. The vaccine created by Johnson & Johnson was designed with accessibility that only requires a single-dose compared to competing vaccines.
Johnson & Johnson is ready to start distribution immediately after approval and promises to work with great urgency making the vaccine available to the public. The FDA scheduled a meeting with the Vaccines and Related Biological Products Advisory Committee to discuss the emergency use authorization on February 26.
The FDA will be following a similar protocol for other COVID-19 vaccines while making all the data available to the public. The committee will also cover the delivery methods of one dose that will be easier logically easier for health-care providers.
The pharmaceutical company #JohnsonandJohnson is preparing to seek U.S. government approval for its one-dose, easily transportable #COVID19 vaccine. And it's the 'one-dose' that's creating a lot of buzz. CGTN's John Terrett reports. pic.twitter.com/O8tGEp5sZk
— CGTN America (@cgtnamerica) February 4, 2021
The data will also cover the testing of COVID-19 variants with 66% protection against COVID-19 and 57% effectiveness against the South Africa (B.1.351) strain. Despite Johnson and Johnson having lower effective rates than the competing vaccines but offers 100% effectiveness in preventing hospitalization and death from COVID-19.
Despite having some competition, Johnson and Johnson have already created a deal back in August with the Department of Health and Human Services for $1 billion to provide 100 million doses. The contract for this deal also includes a stipulation giving the federal government the option of ordering ad additional 200 million doses.
Every Play And Penalty From Super Bowl LV
-
Amazon imposes 10-hour ‘megacycle’ shifts on workers Amazon is known for being one of the biggest retail e-commerce companies...
-
Not once, but twice Legendary country music star Dolly Parton revealed that she was offered the Presidential Medal of...
-
J&J releases COVID-19 vaccine after testing against new virus variants Johnson & Johnson offers new data on their single-dose...
-
The Trump administration is officially over This morning marks the end of the beginning of the Biden administration as...
-
Confederate statue removed from U.S. Capitol The long-standing statue of the Confederate General, Robert E. Lee, was removed from...
-
Advisory panel recommend FDA approval of Modern COVID-19 vaccine The FDA released an analysis of the data for the...
-
Stimulus checks to be approved before the holidays The long-awaited second round of stimulus checks could be coming within...
-
Biden and Harris announced Time’s Person of the Year 2020 Time magazine ends 2020 announcing president-elect Joe Biden and...
-
Medical expert committee to review BNT162b2 vaccine The coronavirus (COVID-19) vaccine created by U.S. pharmaceutical company Pfizer and German...
-
Keeping on the keto diet with healthy snack options Staying on a keto diet while snacking can be tricky...
-
Pfizer and BioNTech planning for FDA approval for COVID-19 vaccine Pfizer and BioNTech apply for emergency use authorization of...
-
Moderna Inc. announces successful study for COVID-19 vaccine Moderna Inc. released the latest data from its late-stage trial for...